Acessibilidade / Reportar erro

Pentavalent antimonial nephrotoxicity in the rat

Disfunção tubular renal em ratos tratados com antimoniais pentavalentes

Abstracts

Aspects of the renal function were assessed in rats treated with the pentavalent antimonials Glucantime (Meglumine Antimoniate, Rhodia) or Pentostam (Sodium Stibogluconate, Wellcome). In dose of 30 mg of Sb v (Glucantime or Pentostam) by 100 mg of weight by day for 30 days, renal functional changes were observed consisting of disturbances in urine concentrating capacity. Such disturbances were expressed by significantly low values of urine osmolality as compared to the basal values previous to the drugs. The decrease in urine osmolality was associated to a significant increase in urinary flow and in negative free-water clearance. There was no alteration in osmolar clearance and in fractional excretion of sodium. These observations suggest an interference of the drugs in the action of the antidiuretic hormone. The disturbance in urine concentration was reversible after a seven days period without the drugs administration. No significant histopathological alterations were observed in the kidneys of the rats treated with the drugs. On the other hand, the rats treated with a high dose of Pentostam (200 mg/100 grams of weight/day) showed the functional and the histopathological alterations of the acute tubular necrosis.

Pentavalent antimonial; Renal function; Urinary concentrating capacity; Acute tubular necrosis; Rat


Estudou-se a função renal de ratos tratados com Glucantime (Antimoniato de Meglumine, Rhodia) e Pentostam (Estibogluconato de Sódio, Wellcome) na dose de 30 mg de Sb v por 100 g de peso por dia, durante 30 dias. Observou-se um distúrio na concentração urinária, que foi reversível 7 dias após cessada a administração das drogas. O estudo histopatológico do rim, por meio da microscopia óptica, não evidenciou alterações significativas. Por outro lado, ratos tratados com altas doses dos antimoniais (200 mg de Sb v por 100 g de peso por dia) mostraram alterações funcionais e histopatológicas renais compatíveis com necrose tubular aguda.


EXPERIMENTAL THERAPEUTIC ASSAYS

Pentavalent antimonial nephrotoxicity in the rat

Disfunção tubular renal em ratos tratados com antimoniais pentavalentes

Joel Paulo R. VeigaI; Rashida KhanamI; Tânia T. RosaI; Luiz F. Junqueira Jr.I; Plínio C. BrantI; Alberto N. RaickII; Horacio FriedmanII; Phillip D. MarsdenI

IDepartamento de Clínica Médica, Faculdade de Ciências da Saúde, Universidade de Brasília, Brasília, DF, Brasil

IIDepartamento de Patologia, Faculdade de Ciências da Saúde, Universidade de Brasília, Brasília, DF, Brasil

Address for correspondence Address for correspondence: Dr. Joel Paulo R. Veiga Departamento de Clínica Médica, Faculdade de Ciências da Saúde, Universidade de Brasília 70910 Brasília, DF, Brasil

SUMMARY

Aspects of the renal function were assessed in rats treated with the pentavalent antimonials Glucantime (Meglumine Antimoniate, Rhodia) or Pentostam (Sodium Stibogluconate, Wellcome). In dose of 30 mg of Sbv (Glucantime or Pentostam) by 100 mg of weight by day for 30 days, renal functional changes were observed consisting of disturbances in urine concentrating capacity. Such disturbances were expressed by significantly low values of urine osmolality as compared to the basal values previous to the drugs. The decrease in urine osmolality was associated to a significant increase in urinary flow and in negative free-water clearance. There was no alteration in osmolar clearance and in fractional excretion of sodium. These observations suggest an interference of the drugs in the action of the antidiuretic hormone. The disturbance in urine concentration was reversible after a seven days period without the drugs administration. No significant histopathological alterations were observed in the kidneys of the rats treated with the drugs. On the other hand, the rats treated with a high dose of Pentostam (200 mg/100 grams of weight/day) showed the functional and the histopathological alterations of the acute tubular necrosis.

Key words: Pentavalent antimonial; Renal function; Urinary concentrating capacity; Acute tubular necrosis; Rat.

RESUMO

Estudou-se a função renal de ratos tratados com Glucantime (Antimoniato de Meglumine, Rhodia) e Pentostam (Estibogluconato de Sódio, Wellcome) na dose de 30 mg de Sbv por 100 g de peso por dia, durante 30 dias. Observou-se um distúrio na concentração urinária, que foi reversível 7 dias após cessada a administração das drogas. O estudo histopatológico do rim, por meio da microscopia óptica, não evidenciou alterações significativas. Por outro lado, ratos tratados com altas doses dos antimoniais (200 mg de Sbv por 100 g de peso por dia) mostraram alterações funcionais e histopatológicas renais compatíveis com necrose tubular aguda.

Full text available only in PDF format.

Texto completo disponível apenas em PDF.

ACKNOWLEDGMENTS

The authors are grateful to Fernando Vicente de Padua for their expert technical assistance.

Recebido para publicação em 30/10/1989.

Research supported by CNPq (40.3789/82, 30.1524/85, 40.7383/85):

  • 1. BRADLEY, G.M. & BENSON, E.S. Examination of the urine. In: DAVIDSOHN, I. & HENRY, J.B., ed. Tood & Sanford. Clinical diagnosis by laboratory methods. 14th. ed. Philadelphia, W. B. Saunders, 1969. p.
  • 2. CHARLAS, R. & BENABADJI, A. Nephrite azotemique au cours du traitement par l'antimoine d'un cas de leishmaniose viscerale infantile. Maroc. méd., 41: 1180-1182, 1962.
  • 3. CHULAY, J.D.; BHATT, S.M.; MUIGAI, R.; HO, M.; GACHIHI, G.; WERE, J.B.O.; CHUNGE, C. & BRYCESON, A.D.M. A comparison of three dosage regimens of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya. J. infect. Dis., 148: 148-155, 1983.
  • 4. CHULAY, J.D.; SPENCER, H.C. & MUGAMBI, M. Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate). Amer. J. trop. Med. Hyg., 34: 702-709, 1985.
  • 5. GAGLIARDI, A.R.T.; VEIGA, J.P.R.; ROSA, T.T. & MARSDEN, P.D. Pentavalent antimonial inhibition of the osmotic effect of oxytocin on the isolated toad bladder. Braz. J. med. biol. Res., 18: 567-571, 1985.
  • 6. GAGLIARDI, A.R.T. Efeito inibitório do antimonial pentavalente sobre a açăo permeabilizante dos peptídios neuro-hipofisários na bexiga isolada do sapo. Brasília, 1986 (Dissertaçăo de Mestrado Faculdade de Cięncias da Saúde da Universidade de Brasília).
  • 7. JOLLIFFE, D.S. Nephrotoxicity of pentavalent antimonials. Lancet, 1: 584, 1985.
  • 8. MARSDEN, P.D. New light on pentavalent antimonials in the treatment of leishmaniais. Rev. Soc. bras. Med. trop., 16: 172-174, 1983.
  • 9. MARSDEN, P.D.; SAMPAIO, R.N.R.; CARVALHO, E.M.; VEIGA, J.P.R.; COSTA, J.L.M. & LLANOS-CUENTAS, E.A. High continuous antimony therapy in two patients with unresponsive mucosal leishmaniasis. Amer. J. trop. Med. Hyg., 34: 710-713, 1985.
  • 10. NEAL, R.A. Chemotherapy of cutaneous leishmaniasis: Leishmania tropica infections in mice. Ann. trop. Med. Parasit., 58: 420-430, 1964.
  • 11. NETO, M.M. Influęncia de dietas com caręncia específica de proteínas, potássio e magnésio sobre a capacidade de concentraçăo urinária em ratos. Ribeirăo Preto, 1978. (Dissertaçăo de Mestrado Faculdade de Medicina de Ribeirăo Preto da Universidade de Săo Paulo).
  • 12. REES, P.H.; KAGER, P.A.; KEATING, M.I. & HOCKMEYER, W.T. Renal clearance of pentavalent antimony (Sodium Stibogluconate). Lancet, 2: 226-229, 1980.
  • 13. SAMPAIO, R.N.R.; ROCHA, R.A.A.; MARSDEN, P.D.; CUBA, C.C. & BARRETO, A.C. Leishmaniose tegumentar americana. Casuística do Hospital Escola da UnB. An. bras. Derm., 55: 69-76, 1980.
  • 14. SAMPAIO, R.N.R.; SAMPAIO, J.H.D. & MARSDEN, P.D. Pentavalent antimony treatment in mucosal leishmaniasis. Lancet, 1: 1097, 1985.
  • 15. SLOT, C. Plasma creatinine determination. A new and specific Jaffe reaction method. Scand. J. clin. Lab. Invest., 17: 381-387, 1965.
  • 16. VEIGA, J.P.R., WOLFF, E.R.; SAMPAIO, R.N.R. & MARSDEN, P.D. Renal tubular dysfunction in patients with mucocutaneous leishmaniasis treated with penta-valent antimonials. Lancet, 2: 569, 1983.
  • 17. VEIGA, J.P.R.; ROSA, T.T.; KIMACHI, T.; WOLFF, E.R.; SAMPAIO, R.N.R.; GAGLIARDI, A.R.T.; JUNQUEIRA JR, L.F.; COSTA, J.L.M. & MARSDEN, P.D. Funçăo renal em pacientes com leishmaniose muco-cutánea tratados com antimoniais pentavalentes. Rev. Inst. Med. trop. S. Paulo, 27: 298-302, 1985.
  • 18
    WORLD HEALTH ORGANIZATION — Report of the informal meeting on the chemotherapy of visceral leishmaniasis. Mimeographed Document TDR/Chem-Leish/VL 82.3, 1982.
  • Address for correspondence:

    Dr. Joel Paulo R. Veiga
    Departamento de Clínica Médica, Faculdade de Ciências da Saúde, Universidade de Brasília
    70910 Brasília, DF, Brasil
  • Publication Dates

    • Publication in this collection
      12 Sept 2006
    • Date of issue
      Aug 1990

    History

    • Received
      30 Oct 1989
    Instituto de Medicina Tropical de São Paulo Av. Dr. Enéas de Carvalho Aguiar, 470, 05403-000 - São Paulo - SP - Brazil, Tel. +55 11 3061-7005 - São Paulo - SP - Brazil
    E-mail: revimtsp@usp.br